Apyx Medical (APYX)
(Delayed Data from NSDQ)
$1.19 USD
-0.04 (-3.25%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $1.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.19 USD
-0.04 (-3.25%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $1.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Zacks News
Apyx Medical (APYX) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Apyx Medical (APYX) likely to gain from J-plasma technology in Q1; margins under pressure.
Apyx Medical (APYX) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Apyx Medical (APYX) closed at $6.31, marking a -0.63% move from the previous day.
Apyx Medical (APYX) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Apyx Medical (APYX) closed at $7.78, marking a -0.51% move from the previous day.
Apyx Medical (APYX) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Apyx (APYX) delivered earnings and revenue surprises of 0.00% and -1.07%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus
by Zacks Equity Research
Conatus (CNAT) makes an improvement with narrower-than-expected loss in the fourth quarter of 2018. Also, revenues beat mark.
Zimmer Biomet (ZBH) Jumps: Stock Rises 6.4%
by Zacks Equity Research
Zimmer Biomet (ZBH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Has Bovie Medical (APYX) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (APYX) Outperforming Other Medical Stocks This Year?
Bovie Medical (APYX) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Bovie Medical (APYX) have what it takes to be a top stock pick for momentum investors? Let's find out.